Most Clozapine Prescribers Satisfied With REMS Program

(MedPage Today) -- Most physician prescribers were satisfied with the FDA's controversial risk evaluation and mitigation strategy (REMS) program for clozapine, survey data showed.
Among 196 doctors who prescribed clozapine, 64% said the positive...